Personalized Medicine
MilliporeSigma Expands Temecula Biotech Hub, Advancing Organoid Research and Personalized Medicine
MilliporeSigma's investments in Temecula, including a new organoid lab and acquisition of HUB Organoids, position the site at the forefront of disease modeling and personalized medicine, while reinforcing its community commitment.
Stanford's Fatima Rodriguez Receives Prestigious 2025 Joseph A. Vita Award for Cardiovascular Research
Dr. Fatima Rodriguez's recognition with the Joseph A. Vita Award highlights significant advancements in personalized cardiovascular risk prediction and prevention strategies that address health disparities across diverse populations.
Lantern Pharma Unveils AI Module to Predict Cancer Treatment Efficacy
Lantern Pharma has developed an artificial intelligence module that enhances predictive capabilities for cancer drug combinations, potentially accelerating personalized oncology treatments and improving clinical success rates.
Genetic Breakthrough Could Personalize Brain Tumor Treatment
Researchers at the University of Kentucky have discovered a genetic biomarker that could help predict which glioblastoma patients may benefit from the drug bevacizumab, offering a new avenue for personalized cancer treatment.
Study Reveals Autoantibodies' Role in Enhancing Cancer Immunotherapy Efficacy
A recent study highlights the potential of autoantibodies in predicting the effectiveness of cancer immunotherapy, offering a new avenue for personalized treatment strategies.
Hone Health's Diagnostic-First Approach Revolutionizes Preventative Care
Hone Health, under CEO Saad Alam, is transforming preventative care by focusing on early diagnostics and personalized health optimization to extend healthspan.
ReVessel Introduces AI-Driven Digital Twin of Human Blood for Personalized Medicine
ReVessel's development of a digital twin for human blood marks a significant advancement in personalized medicine, offering real-time, AI-powered simulations to enhance clinical decision-making.
Eastern Shore Cosmetic Surgery Expands Services with Personalized Hormone Replacement Therapy
Eastern Shore Cosmetic Surgery introduces bioidentical hormone replacement therapy (BHRT), offering a personalized, natural approach to addressing hormone imbalances for both women and men. The new service aims to provide comprehensive wellness solutions tailored to individual patient needs.